| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.05B | +19.2% |
| Cost of Revenue | $7.35B | +18.4% |
| Gross Profit | $6.70B | +19.9% |
| R&D Expense | $820.0M | +7.2% |
| SG&A Expense | $1.81B | +13.3% |
| Operating Income | $869.0M | +258.3% |
| Interest Expense | $480.0M | +13.2% |
| Pre-tax Income | $16.0M | +101.5% |
| Income Tax | -$146.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.53B | +2.3% |
| Accounts Receivable | $98.0M | +8.9% |
| Current Assets | $4.34B | +9.3% |
| Total Assets | $24.51B | -0.5% |
| Current Liabilities | $4.59B | +1.4% |
| Long-term Debt | $6.74B | -4.5% |
| Total Liabilities | $13.24B | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.60B | +71.0% |
| Capital Expenditures | $144.0M | -9.4% |
| Investing Cash Flow | -$811.0M | -34.7% |
| Financing Cash Flow | -$469.0M | -315.0% |
| Free Cash Flow | $1.46B | +87.4% |
| -221.7% |
| Net Income | $162.0M | +113.4% |
| EPS (Basic) | $0.24 | +103.5% |
| EPS (Diluted) | $0.24 | +103.5% |
| Stockholders' Equity |
| $9.29B |
| -7.5% |